RARE Average Annual Return 10 Years
Growth of $10,000.00
Without Dividends Reinvested Into RARE


Also see:
RARE stock yearly return 2014
RARE stock yearly return 2015
RARE stock yearly return 2016
RARE stock yearly return 2017
RARE stock yearly return 2018
RARE stock yearly return 2019
RARE stock yearly return 2020
RARE stock yearly return 2021
RARE stock yearly return 2022
RARE stock yearly return 2023
RARE YTD return
Compare RARE average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Start date: 03/31/2014
End date: 03/28/2024
Start price/share: $48.89
End price/share: $46.69
Dividends collected/share: $0.00
Total return: -4.50%
RARE Average Annual Return: -0.46%
Starting investment: $10,000.00
Ending investment: $9,549.41
Years: 10.00


RARE average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
Ultragenyx Pharmaceutical is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of products for the treatment of genetic diseases. Co. has four commercially approved products, Crysvita® (burosumab) for the treatment of X-linked hypophosphatemia and tumor-induced osteomalacia, Mepsevii® (vestronidase alfa) for the treatment of mucopolysaccharidosis VII, or Sly Syndrome, Dojolvi® (triheptanoin) for the treatment of long-chain fatty acid oxidation disorders, and Evkeeza® (evinacumab) for the treatment of homozygous familial hypercholesterolemia. The RARE average annual return 10 years is shown above.

The Average Annual Return on the RARE average annual return 10 years page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether RARE average annual return 10 years or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the RARE average annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes

Email EnvelopeFree RARE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Ultragenyx Pharmaceutical (RARE) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

RBOT Average Annual Return
RCEL Average Annual Return
RCKT Average Annual Return
RCUS Average Annual Return
RDHL Average Annual Return
RDNT Average Annual Return
RDY Average Annual Return
REGN Average Annual Return
RENB Average Annual Return
REPL Average Annual Return
More Healthcare companies »

What has the average annual return been for RARE over the past ten years?
✔️Accepted answer: The ten year RARE average annual return has been -0.46%.

What start date was used in your RARE average annual return calculation?
✔️Accepted answer: The start date was 03/31/2014.

What end date was used in your RARE average annual return calculation?
✔️Accepted answer: The end date was 03/28/2024.

If I had invested $10,000 into RARE ten years ago, how much would I have today?
✔️Accepted answer: Today, as of 03/28/2024, you would have $9,549.41.

What does that work out to on a total return basis?
✔️Accepted answer: The RARE ten year total return ending 03/28/2024 works out to -4.50%.


Also see:
RARE stock yearly return 2014
RARE stock yearly return 2015
RARE stock yearly return 2016
RARE stock yearly return 2017
RARE stock yearly return 2018
RARE stock yearly return 2019
RARE stock yearly return 2020
RARE stock yearly return 2021
RARE stock yearly return 2022
RARE stock yearly return 2023
RARE YTD return
 

RARE Average Annual Return 10 Years | www.AverageAnnualReturn.com | Copyright © 2021 - 2024, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.